Merdury Biopharmaceutical Corporation (TPEX:6932)
8.10
+0.11 (1.38%)
Mar 6, 2026, 1:00 PM CST
Revenue by Segment
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.